Mitoxantrone – an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue
Abstract
Mitoxantrone is an antineoplastic agent approved for clinical use in the secondary progressive phase of multiple sclerosis (MS). Several scientific reports indicate that mitoxantrone acts through the induction of short-term cell lysis at high concentrations and long-term induction of programmed cell death at lower concentrations of antigen-presenting cells. In this paper, we present the potential cytotoxic effects of mitoxantrone on the cells of the immune system, whose activity is associated with their degenerative effects on axonal myelin sheaths. The article also evaluates the results from the hospital treatment of patients diagnosed with MS. The presented data indicate that, apart from the cytostatic properties, mitoxantrone also exhibits side effects of its clinical application. This drug has high cardiotoxicity, and is associated with decreased left ventricular ejection fraction and increased risk of congestive heart failure. Therefore researchers are currently looking for new substances that can reduce the toxic effects of mitoxantrone in healthy tissues, resulting in the generation of reactive oxygen species during its metabolism.
Authors and Affiliations
Marzena Szwed
Results of antiviral treatment of patients with chronic hepatitis C: experience of Poznan centre
Introduction: Hepatitis C virus (HCV) infection in Poland affects approximately 750 thousand persons. The prevention of cirrhosis and hepatocellular carcinoma, of which approximately 20% of patients with chronic hepatit...
Procesy komórkowe oraz odpowiedzi immunologiczne na terapię fotodynamiczną w onkologii
Stem and progenitor cells in biostructure of blood vessel walls
Development of vascular and hematopoietic systems during organogenesis occurs at the same time. During vasculogenesis, a small part of cells does not undergo complete differentiation but stays on this level, “anchored” i...
Mutacje genów niekolagenowych we wrodzonej łamliwości kości – znaczenie produktów tych genów w biosyntezie kolagenu i patogenezie choroby
Niedawne badania ujawniły, że fenotyp „kruchych kości” we wrodzonej łamliwości kości (osteogenesis imperfecta – OI) jest spowodowany nie tylko przez dominujące mutacje genów kodujących kolagen typu I, ale również recesy...
Glikozylacja IgG w chorobach autoimmunizacyjnych
Przeciwciała klasy G są najobficiej występującymi glikozylowanymi białkami surowicy ludzkiej. Wszystkie cząsteczki IgG są N-glikozylowane we fragmencie Fc, a 10-30% zawiera również N-glikany dołączone do Fab. Fragment Fc...